Ardelyx, Inc(NASDAQ:ARDX) 
Ardelyx, Inc., a biopharmaceutical company, develops and sells medicines for the treatment of kidney and cardiorenal diseases in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase 3 clinical trial for the treatment of patients with irr...
Website: http://www.ardelyx.com
Founded: 2007
Full Time Employees: 88
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 4.59
H 4.71
L 4.45
C 4.55
V 8,788,271
10EMA 4.55
20EMA 4.55
60EMA 4.55
120EMA 4.55
250EMA 4.55